Enhancement of in vivo hypoglycemic effect of gliclazide by developing self-microemulsifying pellet dosage form
Abstract Background The present research was aimed to develop a self-microemulsifying drug delivery system (SMEDDS) pellet to increase the dissolution rate and in vivo hypoglycemic effect of gliclazide. Gliclazide belongs to BCS class 2 and it exhibits dissolution rate-limited absorption. Thus, diss...
Saved in:
Main Authors: | Hetal Patel (Author), Niharika Pandey (Author), Bhoomi Patel (Author), Ketan Ranch (Author), Kunjan Bodiwala (Author), Bhavin Vyas (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics and substantiation of the use of pellets as a modern dosage form on the market of Ukraine
by: Anna Yerkhova, et al.
Published: (2021) -
Multivariate Chemometric Assisted Analysis of Metformin Hydrochloride, Gliclazide and Pioglitazone Hydrochloride in Bulk Drug and Dosage Forms
by: Vipin Saini, et al.
Published: (2013) -
Development and validation of stability-indicating UPLC method for the determination of gliclazide and its impurities in pharmaceutical dosage forms
by: Kunal Bhattacharya, et al.
Published: (2021) -
Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system
by: Hetal Thakkar, et al.
Published: (2011) -
Preparation and in vitro-in vivo evaluation of intestinal retention pellets of Berberine chloride to enhance hypoglycemic and lipid-lowing efficacy
by: Guofei Li, et al.
Published: (2019)